Cancer Biotherapy and Radiopharmaceuticals

Papers
(The H4-Index of Cancer Biotherapy and Radiopharmaceuticals is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Telomere-Related Gene Risk Model for Prognosis and Immune Landscape in Hepatocellular Carcinoma33
Long Noncoding RNA Regulator of Reprogramming Regulates Cell Growth, Metastasis, and Cisplatin Resistance in Gastric Cancer via miR-519d-3p/HMGA2 Axis26
Serum-Derived Exosomes-Mediated Circular RNA ARHGAP10 Modulates the Progression of Non-Small Cell Lung Cancer Through the miR-638/FAM83F Axis25
Knockdown of Circ_CCNB2 Sensitizes Prostate Cancer to Radiation Through Repressing Autophagy by the miR-30b-5p/KIF18A Axis23
miR-146a Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel by Downregulating IRAK122
LncRNA MORT Overexpression Inhibits Cancer Cell Migration and Invasion in Hepatocellular Carcinoma by Downregulating NOTCH120
Efficacy and Safety of Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Patients with Lung Cancer Who Were Complicated with Hemoptysis20
Expression of HER2 and BRCA1 Correlates with Prognosis in Patients with Breast Cancer After Radiotherapy: 20
An LNM-Associated Gene Signature for Prognostic Prediction and Immune Profiling in Head and Neck Squamous Cell Carcinoma19
Chelation-Tamoxifen Conjugates for Imaging of Estrogen Receptors19
IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma17
Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal Radiopharmaceuticals15
Radiopharmaceutical Advancements in Anesthesia and Orthopedic Oncology: A Paradigm Shift in Cancer Biotherapy and Targeted Therapy15
Long Non-Coding RNA AC008972.1 as a Novel Therapeutic Target for Prostate Cancer14
0.097676992416382